BlackRock »

Immunitybio shares owned by BlackRock

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $44M 12M 3.72

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Immunitybio

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Geode Capital Management
Bank of America Corporation
Susquehanna International
Charles Schwab Investment Management
Cormorant Asset Management
Northern Trust
Jpmorgan Chase & Co
Goldman Sachs Group
Citadel Advisors
Jane Street
First Trust Advisors

View all funds holding Immunitybio